Koninklijke Philips (PHG) Cash from Investing Activities Growth (3y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.31% |
| Jun 30, 2025 | 22.69% |
| Dec 31, 2024 | 47.37% |
| Jun 30, 2024 | 64.31% |
| Dec 31, 2023 | 23.20% |
| Jun 30, 2023 | 13.37% |
| Dec 31, 2022 | -31.48% |
| Jun 30, 2022 | -21.27% |
| Dec 31, 2021 | -35.30% |
| Jun 30, 2021 | -73.19% |
| Dec 31, 2020 | 26.25% |
| Jun 30, 2020 | -13.31% |
| Dec 31, 2019 | 17.28% |
| Jun 30, 2019 | 2.04% |
| Dec 31, 2018 | 7.28% |
| Jun 30, 2018 | 23.57% |
| Dec 31, 2017 | -45.22% |
| Jun 30, 2016 | 1.11% |
| Mar 31, 2016 | 5.82% |
| Dec 31, 2015 | -21.04% |
| Sep 30, 2015 | -36.07% |
| Jun 30, 2015 | -56.99% |
| Mar 31, 2015 | -94.81% |
| Dec 31, 2014 | 10.97% |
| Jun 30, 2013 | -12.61% |
| Mar 31, 2013 | -47.73% |
| Dec 31, 2012 | -54.80% |